All Stories

  1. Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do

    Article • Journal of Viral Hepatitis, July 2020, Wiley

    Javier Crespo

  2. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo, Dr Carmelo Garcia-Monzon , Dr Eduardo EVG Vilar Gomez

  3. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

    Article • Hepatology Communications, May 2018, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo, Radan Bruha

  4. High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

    Article • Liver International, June 2017, Wiley

    Professor Valentín Cuervas-Mons, Professor Manuel Romero-Gómez, Javier Crespo, Vanessa Hontangas, JUAN JOSE SANCHEZ

  5. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry

    Article • Hepatology, April 2017, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo

  6. Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project

    Article • Hepatology, May 2014, Wolters Kluwer Health

    Javier Crespo

  7. Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice

    Article • Liver International, April 2014, Wiley

    Javier Crespo